MOHAMMED N AL HALLAK to Humans
This is a "connection" page, showing publications MOHAMMED N AL HALLAK has written about Humans.
Connection Strength
0.029
-
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy. Cancer Res Commun. 2024 10 01; 4(10):2598-2609.
Score: 0.005
-
The phase I/II eNRGy trial: Zenocutuzumab in?patients with cancers harboring NRG1 gene fusions. Future Oncol. 2024; 20(16):1057-1067.
Score: 0.005
-
Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and Opportunities. J Gastrointest Cancer. 2024 Jun; 55(2):519-533.
Score: 0.004
-
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers. Mol Cancer Ther. 2023 Dec 01; 22(12):1422-1433.
Score: 0.004
-
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC). Lung Cancer. 2021 10; 160:92-98.
Score: 0.004
-
Gastrointestinal stromal tumor: a review of current and emerging therapies. Cancer Metastasis Rev. 2021 06; 40(2):625-641.
Score: 0.004
-
Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020 12; 39(4):1179-1203.
Score: 0.004